Loading...
Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients
BACKGROUND: Early screening and intervention therapies are crucial to improve the prognosis of hepatocellular carcinoma (HCC) patients with bone metastasis. We aimed to identify serum lncRNA as a prediction biomarker in HCC bone metastasis. METHODS: The expression levels of lnc34a in serum samples f...
Saved in:
| Published in: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7885499/ https://ncbi.nlm.nih.gov/pubmed/33588789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-07808-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|